15 research outputs found
Bradyrhizobium neotropicale sp. nov., isolated from effective nodules of Centrolobium paraense
Root nodule bacteria were isolated from Centrolobium paraense Tul. grown in soils from the Amazon region, State of Roraima (Brazil). 16S rRNA gene sequence analysis of seven strains (BR 10247(T), BR 10296, BR 10297, BR 10298, BR 10299, BR 10300 and BR 10301) placed them in the genus Bradyrhizobium with the closest neighbours being the type strains of Bradyrhizobium paxllaeri (98.8 % similarity), Bradyrhizobium icense (98.8 %), Bradyrhizobium lablabi (98.7 %), Bradyrhizobium jicamae (98.6 %), Bradyrhizobium elkanii (98.6 %), Bradyrhizobium pachyrhizi (98.6%) and Bradyrhizobium retamae (98.3 %). This high similarity, however, was not confirmed by the intergenic transcribed spacer (ITS) 16S-23S rRNA region sequence analysis nor by multi-locus sequence analysis. Phylogenetic analyses of five housekeeping genes (dnaK, gin/I, gyrB, recA and rpoB) revealed Bradyrhizobium iriomotense EKO5(T) (=LMG 24129(T)) to. be the most closely related type strain (95.7% sequence similarity or less). Chemotaxonomic data, including fatty acid profiles [major components being C-16:0 and summed feature 8 (18:1 omega 6c/18:1 omega 7c)] DNA G+C content, slow growth rate and carbon compound utilization patterns, supported the placement of the novel strains in the genus Bradyrhizobium. Results of DNA-DNA relatedness studies and physiological data (especially carbon source utilization) differentiated the strains from the closest recognized species of the genus Bradyrhizobium. Symbiosis-related genes for nodulation (nodC) and nitrogen fixation (nil/-I) placed the novel species in a new branch within the genus Bradyrhizobium. Based on the current data, these seven strains represent a novel species for which the name Bradyrhizobium neotropicale sp. nov. is proposed. The type strain is BR 10247(T) (=HAMBI 3599(T))
Influence of previous Zika virus infection on acute dengue episode.
BackgroundThe co-circulation of flaviviruses in tropical regions has led to the hypothesis that immunity generated by a previous dengue infection could promote severe disease outcomes in subsequent infections by heterologous serotypes. This study investigated the influence of antibodies generated by previous Zika infection on the clinical outcomes of dengue infection.Methodology/principal findingsWe enrolled 1,043 laboratory confirmed dengue patients and investigated their prior infection to Zika or dengue. Severe forms of dengue disease were more frequent in patients with previous Zika infection, but not in those previously exposed to dengue.Conclusions/significanceOur findings suggest that previous Zika infection may represent a risk factor for subsequent severe dengue disease, but we did not find evidence of antibody-dependent enhancement (higher viral titer or pro-inflammatory cytokine overexpression) contributing to exacerbation of the subsequent dengue infection
Screening of reactive peptides using monoclonal antibodies.
(A) Heatmap matrix of peptides assessed with monoclonal specific antibodies against ZIKV or DENV in an indirect IgG ELISA platform. Highest scores were selected for soluble synthesis. Peptide ZV-53 was not stable in soluble form and excluded from analysis. (B) IgG pepELISA for validation of soluble peptides. Serum samples from patients validated with PRNT were evaluated on plates with DV-15, DV-20, ZV-54, and ZV-107.</p
Codebook.
BackgroundThe co-circulation of flaviviruses in tropical regions has led to the hypothesis that immunity generated by a previous dengue infection could promote severe disease outcomes in subsequent infections by heterologous serotypes. This study investigated the influence of antibodies generated by previous Zika infection on the clinical outcomes of dengue infection.Methodology/Principal findingsWe enrolled 1,043 laboratory confirmed dengue patients and investigated their prior infection to Zika or dengue. Severe forms of dengue disease were more frequent in patients with previous Zika infection, but not in those previously exposed to dengue.Conclusions/SignificanceOur findings suggest that previous Zika infection may represent a risk factor for subsequent severe dengue disease, but we did not find evidence of antibody-dependent enhancement (higher viral titer or pro-inflammatory cytokine overexpression) contributing to exacerbation of the subsequent dengue infection.</div
Distribution of dengue-confirmed cases in São José do Rio Preto, São Paulo State, during 2019 epidemic, according to months and epidemiological weeks.
Distribution of dengue-confirmed cases in São José do Rio Preto, São Paulo State, during 2019 epidemic, according to months and epidemiological weeks.</p
Measure of differential diagnostic performance for DENV NS1 protein, ZIKV NS1 protein, and for peptides DV-15, DV-20, and ZV-54.
Measure of differential diagnostic performance for DENV NS1 protein, ZIKV NS1 protein, and for peptides DV-15, DV-20, and ZV-54.</p
Differential diagnostic performance of the pepELISA and standard NS1 ELISA using validated samples.
Receiver Operating Characteristic (ROC) curves of pepELISA for the peptides (A) DV-15; (B) DV-20; (C) ZV-54; and standard ELISA against (D) DENV NS1 mix, and (E) ZIKV NS1. ‘Control’ identifies samples considered true negatives, and ‘Patients’ identifies samples considered true positives. Performance is demonstrated in True Positive Rate (Sensitivity %) versus False Positive Rate (100%—Specificity %). (TIF)</p
Characteristics of 1,043 dengue-confirmed cases eligible between December 2018 and November 2019, in São José do Rio Preto, São Paulo State.
Characteristics of 1,043 dengue-confirmed cases eligible between December 2018 and November 2019, in São José do Rio Preto, São Paulo State.</p
Flow of sample selection for dengue-suspected cases with up to 7 days of symptoms onset.
Flow of sample selection for dengue-suspected cases with up to 7 days of symptoms onset.</p